Akari Therapeutics Plc 10-K filing
Filed 2026-03-30 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001493152-26-013664
- Form type
- 10-K
- CIK
- 0001541157
- Primary document
- https://www.sec.gov/Archives/edgar/data/1541157/000149315226013664/form10-k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Akari Therapeutics Plc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-17.3M | - | - |
| Net Income | $-17.3M | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Cash And Equivalents | $0 | - | - |
| Total Assets | $47.9M | - | - |
| Total Liabilities | $19.6M | - | - |
| Shareholders Equity | $28.3M | - | - |
| Operating Cash Flow | $-10.6M | - | - |